MAJOR PAPERS:

• Jarrett Lilien, E-Trade Financial Corporation's (NASDAQ: ETFC) president and COO, who lost out on the CEO job last month to Donald Layton, is going to resign from the online brokerage firm, the Wall Street Journal reported; Layton doesn't plan to fill the position.
• Chinese Internet search firm Baidu.com Inc (NASDAQ: BIDU) is poised for aggressive growth but must also confront a number of obstacles, according to the Wall Street Journal's "Heard in Asia," including a number of lawsuits regarding its music services and a vacancy in the CFO position.
• Alibaba Group, a Chinese Internet company , is in advanced talks with investors to finance its acquisition of Yahoo! Inc's (NASDAQ: YHOO) stake to expand its management independence, the Wall Street Journal reported.

OTHER PAPERS:

• According to inside sources, the New York Post reported that billionaire Joseph Lewis and former Bear Stearns Companies Inc (NYSE: BSC) CEO Jimmy Cayne are looking for a white knight that could surpass JPMorgan Chase & Co's (NYSE: JPM) takeover offer for Bear Lewis and Cayne have reportedly reached out to several private equity firms and overseas banks, including Barclays Plc (NYSE: BCS) and Credit Suisse Group (NYSE: CS).

WEB SITES:

• Medical supplies boss Michael Mastromarino, accused of stealing the body parts of around 1,000 corpses, has pleaded guilty to several charges in a deal with prosecutors. The BBC News reported that the Biomedical Tissue Services company shipped bones, skin and tendons to tissue-processing companies such as LifeCell Corporation (NASDAQ: LIFC) and Tutogen Medical Inc (AMEX: TTG), which are in turn facing hundreds of civil lawsuits.

Here are some highlights from this past week's earnings coverage from BloggingStocks:

• Astec Industries Inc. (NASDAQ: ASTE) beat expectations and raised its guidance.
• Blockbuster Inc. (NYSE: BBI) fourth-quarter profit fails to offset the full-year loss.
• China Techfaith Wireless Communication Technology (NASDAQ: CNTF) beat analysts' expectations.
• Costco Wholesale Corp. (NASDAQ: COST) met analysts' estimates, buoyed by higher fuel prices.
• FTI Consulting Inc. (NYSE: FCN) beat expectations and raised its full-year guidance.
• H&R Block Inc. (NYSE: HRB) narrowed its loss due to higher sales and smaller subprime losses.
• Jackson Hewitt Tax Service Inc. (NYSE: JTX) missed estimates as third-quarter profits declined sharply.
• LifeCell Corp. (NASDAQ: LIFC) beat fourth-quarter estimates and offered full-year guidance.
• Marvell Technology Group (NASDAQ: MRVL) lowered its first-quarter forecast , sending shares lower.
• Porsche AG (OTC: PSEPF) profit soared on strong sales of its Cayenne.
• S1 Corp. (NASDAQ: SONE) beat expectations and offered full-year guidance.
• Saks Inc. (NYSE: SKS) fourth-quarter profit nearly doubled, but full-year profit declined.
• Urban Outfitters Inc. (NASDAQ:URBN) beat expectations on strength in same-store sales.
• Walgreen Co. (NYSE: WAG) reports strong same-store sales ahead of its quarterly results.

Also, see Timothy Sykes's take on Warren Buffett's annual letter to Berkshire Hathaway (NYSE: BRK.A) shareholders. Zac Bissonnette is interested in where earnings actually come from. And Saks, Costco, and other retailers saw stronger February same-store sales despite recession concerns, but JC Penney Co. (NYSE: JCP) didn't feel the love.

Upcoming results to watch for include Kroger Co. (NYSE: KR), Boston Beer Co. (NYSE: SAM), J. Crew Group Inc. (NYSE: JCG), Jones Soda Co. (NASDAQ: JSDA), Blackstone Group (NYSE: BX), and Men's Wearhouse Inc. (NYSE: MW).

Visit AOL Money & Finance for more earnings coverage.

LifeCell Corporation (NASDAQ: LIFC) provides surgeons with regenerative and reconstructive tissue matrices for soft tissue repair. Products include AlloDerm, for plastic reconstructive, general surgical, burn and periodontal procedures; Strattice, for plastic reconstructive and general surgical procedures; Graftjacket, for orthopedic applications and lower extremity wounds; Allocraft, for bone grafting procedures; and Repliform, for urogynecologic surgical procedures. The materials are sold in the US and abroad, through a direct sales force and through such distributors as Boston Scientific (NYSE: BSX).

The company pleased investors last week, when it reported Q4 EPS of 19 cents and revenues of $52.6 million. Analysts had been expecting 17 cents and $52.2 million. Management also guided FY08 EPS to $0.98-$1.06 ($1.04 consensus) and FY08 revenues to $233-$243 million ($238.89M consensus). Needham subsequently upgraded the issue to "strong buy" and boosted its price target to $55.

MOST NOTEWORTHY: 012Smile.com, Lifecell and Genoptix were today's noteworthy initiations:

• 012Smile.com (NASDAQ: SMLC) was initiated with an Outperform rating and a $16 target at CIBC World Markets and RBC Capital and with an Overweight rating and $14.75 target at Thomas Weisel. CIBC believes the company is one of the least expensive smart-build competitive carriers in the world. The firm believes the company is poised to gain market share in newly opened local and wireless markets, and sees room for the company to expand its customer base in Israel. Cowen, which started shares with an Outperform rating, believes SMLC backing by Eurocom provides the company with significant clout and financial backing. The firm sees upside from new voice over broadband and wireless services.
  
• Banc of America resumed coverage of Lifecell (NASDAQ: LIFC) with a Neutral rating and $48 target and prefers to wait for a better entry point or evidence of better than expected Strattice uptake.
  
• The firm also started Genoptix (NASDAQ: GXDX) with a Buy rating and $36 target, as they believe the funds raised in the company's IPO will help drive annual EPS growth of 35% on a long-term basis, leading to higher valuation levels.

OTHER INITIATIONS:

• JP Morgan initiated Fred's Inc. (NASDAQ: FRED) with a Neutral rating.
  
• UBS started Vulcan Materials Company (NYSE: VMC) with a Sell rating and $85 target and Martin Marietta (NYSE: MLM) with a Neutral rating and $137 target.

MOST NOTEWORTHY: Sanofi-Aventis, Lifecell, Mylan Labs, Panera Bread and Norsk Hydro were today's noteworthy upgrades:

• Societe Generale upgraded shares of Sanofi-Aventis (NYSE: SNY) to Buy from Hold as they believe pipeline maturation over the next 12 months can drive the stock higher.
  
• Piper upgraded shares of Lifecell (NASDAQ: LIFC) to Outperform from Market Perform after their recent survey indicated that AlloDerm remains the leading biologic hernia mesh on the market and competition is making little headway.
  
• JP Morgan upgraded Mylan Labs (NYSE: MYL), Panera Bread (NASDAQ: PNRA) and Norsk Hydro (NYSE: NHY) to Overweight from Neutral. The firm upgraded Mylan based on its position in the global generics market and above-average growth; Panera was upgraded on valuation, as they believe the recent operating risk is now behind the company; Norsk Hydro was upgraded, as they believe the value of the company's aluminum assets are higher than the current share price suggests.

OTHER UPGRADES:

• HSBC upgraded Ride Aid (NYSE: RAD) to Neutral from Underweight.
  
• UBS upgraded Standard Pacific (NYSE: SPF) and Ciena (NASDAQ: CIEN) to Neutral from Sell and Sherwin-Williams (NYSE: SHW) to Buy from Neutral.
  
• Goldman added Cytec Industries (NYSE: CYT) to its Conviction Buy List.

MOST NOTEWORTHY: Celgene (CELG), Sysco (SYY), Kinetic Concepts (KCI), BioMimtic Therapeutics (BMTI) and Lifecell Corp (LIFC) were today's noteworthy initiations:

• William Blair believes Celgene (NASDAQ: CELG) has the best growth profile in large-cap biotechnology and initiated shares with an Outperform rating.

• Citigroup views Sysco (NYSE: SYY) as the dominant leader in the foodservice distribution industry, initiating shares with a Buy rating, and feels the company will continue to take market share from its peers. The firm thinks the current valuation reflects the perception that Sysco may perform poorly in the near-term, which they disagree with.

• Wachovia started Kinetic Concepts (NYSE: KCI) with a Market Perform, citing competitive pressures and mature markets for its rating.

• Wachovia is positive on BioMimetic Therapeutics (NASDAQ: BMTI), initiating shares with an Outperform, based on strong rhPDGF technology, strategy, and management team.

• Wachovia is positive on Lifecell Corp's (NASDAQ: LIFC) Strattice, a porcine tissue matrix, which improves the company's international exposure and provides opportunities in new markets, initiating shares with an Outperform...

OTHER INITIATIONS:

• Credit Suisse initiated Community Health (NYSE: CYH) and Universal Health (NYSE: UHS) with Outperform ratings, LifePoint (NASDAQ: LPNT) with a Neutral rating, and Health Management (NYSE: HMA) and Tenet Healthcare (NYSE: THC) with Underperform ratings.

Analyst summaries provided by TheFlyOnTheWall.com (subscription required).